Role For Gefitinib In Asian Nonsmokers With Lung Cancer Established

The targeted therapy gefitinib should be considered a first-line therapy for nonsmoking Asian patients with adenocarcinoma of the lung, one of the most common types of lung cancer, suggests a presentation at the 33rd Congress of the European Society for Medical Oncology.

Read the whole article on Science Daily

More from Science Daily